Menu

Filtros : "Brazilian Journal of Cardiovascular Surgery" "AZUL DE METILENO" Removido: "Indexado no : Scielo" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico-carta/editorial

    Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…" (2021)

    Evora, Paulo Roberto Barbosa; Gomes, Walter J.

    Source: Brazilian Journal of Cardiovascular Surgery. Unidade: FMRP

    Subjects: CIRCULAÇÃO EXTRACORPÓREA, AZUL DE METILENO, CHOQUE, FARMACOTERAPIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      EVORA, Paulo Roberto Barbosa e GOMES, Walter J. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…". Brazilian Journal of Cardiovascular Surgery. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.21470/1678-9741-2021-0957. Acesso em: 06 ago. 2024. , 2021

    • APA

      Evora, P. R. B., & Gomes, W. J. (2021). Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…". Brazilian Journal of Cardiovascular Surgery. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.21470/1678-9741-2021-0957

    • NLM

      Evora PRB, Gomes WJ. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…" [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): I-II.[citado 2024 ago. 06 ] Available from: https://doi.org/10.21470/1678-9741-2021-0957

    • Vancouver

      Evora PRB, Gomes WJ. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…" [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): I-II.[citado 2024 ago. 06 ] Available from: https://doi.org/10.21470/1678-9741-2021-0957

  • Artigo de periodico

    After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery (2021)

    Evora, Paulo Roberto Barbosa; Soares, Ricardo Oliveira dos Santos; Bassetto, Solange; Martins, Maria Auxiliadora; Silva, Fábio Luis da; Basile-Filho, Anibal

    Source: Brazilian Journal of Cardiovascular Surgery. Unidade: FMRP

    Subjects: PROCEDIMENTOS CIRÚRGICOS CARDÍACOS, HIPOTENSÃO, AZUL DE METILENO, FARMACOTERAPIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      EVORA, Paulo Roberto Barbosa et al. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery. Brazilian Journal of Cardiovascular Surgery, v. 36, n. 3, p. 406-411, 2021Tradução . . Disponível em: https://doi.org/10.21470/1678-9741-2021-0955. Acesso em: 06 ago. 2024.

    • APA

      Evora, P. R. B., Soares, R. O. dos S., Bassetto, S., Martins, M. A., Silva, F. L. da, & Basile-Filho, A. (2021). After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery. Brazilian Journal of Cardiovascular Surgery, 36( 3), 406-411. doi:10.21470/1678-9741-2021-0955

    • NLM

      Evora PRB, Soares RO dos S, Bassetto S, Martins MA, Silva FL da, Basile-Filho A. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): 406-411.[citado 2024 ago. 06 ] Available from: https://doi.org/10.21470/1678-9741-2021-0955

    • Vancouver

      Evora PRB, Soares RO dos S, Bassetto S, Martins MA, Silva FL da, Basile-Filho A. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): 406-411.[citado 2024 ago. 06 ] Available from: https://doi.org/10.21470/1678-9741-2021-0955
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024